Still, these results suggest that the circadian clock can regulate TMZ toxicity in GBM also in humans, and that adapting TMZ administration to the peak of BMAL1 expression in GBM cells can enhance its efficiency,60 (Fig. 1c). The gene discussed is CLOCK; the disease is glioblastoma.